Showing results (391-400 of 653) with videos related to

Sort By:
Pageof 66
World Journal of Gastroenterology|July 16, 2014
Novel diagnostics for aggravating pancreatic fistulas at the acute phase after pancreatectomyMitsuro Kanda, Tsutomu Fujii, Hideki Takami, et al.
Oncotarget|October 21, 2017
An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinomaMitsuro Kanda, Kenta Murotani, Hiroyuki Sugimoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 10, 2017
Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort studyNaoki Hiki, Michitaka Honda, Tsuyoshi Etoh, et al.
Hepato-Gastroenterology|December 2, 2014
Pattern of first recurrent lesions in pancreatic cancer: hepatic relapse is associated with dismal prognosis and portal vein invasionMasaya Suenaga, Tsutomu Fujii, Mitsuro Kanda, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 17, 2016
Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trialYasuhiro Kodera, Naoto Takahashi, Takaki Yoshikawa, et al.
Pancreas|December 3, 2024
Phase II Randomized Controlled Trial to Evaluate the Supportive Effect of Koujin (TJ-3020) Powder in Gemcitabine and Nab-Paclitaxel-Treated Unresectable or Recurrent Pancreatic CancerTomohisa Otsu, Hideki Takami, Suguru Yamada, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2020
Indications for neoadjuvant treatment based on risk factors for poor prognosis before and after neoadjuvant chemotherapy alone in patients with locally advanced rectal cancerAtsushi Ogura, Kay Uehara, Toshisada Aiba, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 19, 2019
Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancerYoshiyasu Kato, Suguru Yamada, Mitsuru Tashiro, et al.
British Journal of Cancer|February 3, 2021
Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathwayTakashi Miwa, Mitsuro Kanda, Dai Shimizu, et al.
Anticancer Research|August 19, 2007
A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study)Yasuhiro Kodera, Seiji Ito, Yoshinari Mochizuki, et al.
Pageof 66